Treace Medical Concepts makes surgical systems and implants for correcting bunions and related midfoot deformities. It last closed at $4.44 on Nov 17, up 0.45% on the day. TMCI last reported earnings on Fri, Nov 6, 2026.
Only 1 firm rated TMCI in the past 90 days, not enough for a consensus
Average 12-month target
$6.50
▲ 46.4% upside
Based on 1 analyst who set a price target on TMCI in the past 90 days. The average target is $6.50, with a high of $6.50 and a low of $6.50, compared with the last close of $4.44.
Low $6.50Avg $6.50High $6.50
Blue marker: last close $4.44
Highest target$6.50
Average target$6.50
Lowest target$6.50
Latest rating changes
StifelUpgrade
Nov 9Buy$6.50
Truist SecuritiesTarget raised
Aug 10Hold$4 → $5
Truist SecuritiesMaintained
Jul 16Hold$4
Date
Firm
Action
Rating
Price target
Nov 9
Stifel
Upgrade
Buy
$6.50
Aug 10
Truist Securities
Target raised
Hold
$4 → $5
Jul 16
Truist Securities
Maintained
Hold
$4
Loading…
Technical Analysis
TMCI · as of the Nov 17 close · updated after every close
Uptrend
The stock sits between its 20 and 50 day averages. It is 24% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 48). The nearest support is the 50 day average at $4.42, and the nearest resistance the swing high (Jun 12) at $4.47.
Short trendBullish
Long trendBullish
MomentumImproving
StretchNormal
VolatilityHigh, 10.0%/day
Key levels
$5.4052 week high+21.6%
$4.58Pivot R1+3.2%
$4.5720 day average+2.9%
$4.49Pivot+1.1%
$4.47Swing high (Jun 12)+0.7%
$4.44100 day average+0.0%
$4.44Last close
$4.4250 day average−0.5%
$4.38Swing low (Sep 21)−1.4%
$4.35Pivot S1−2.0%
$3.36200 day average−24.3%
$1.1752 week low−73.6%
Indicators
RSI (14)
48.26
Middle of its range
Neutral
MACD
0.13
Above its signal line
Bullish
Stochastic
64.9
Middle of its range
Neutral
ADX (14)
14.1
No clear trend
Williams %R
-48.9
Oversold below −80, overbought above −20
Neutral
CCI (20)
-18.1
Oversold below −100, overbought above 100
Neutral
Rate of change
+3.7%
Change over 10 sessions
Bullish
ATR (14)
$0.45
Typical daily range, 10.0% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
Bounce inside a longer downtrend
Short trendBullish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityNormal, 15.7%/day
Key levels
$5.4052 week high+21.6%
$4.58Pivot R1+3.2%
$4.5720 day average+2.9%
$4.49Pivot+1.1%
$4.47Swing high (Jun 12)+0.7%
$4.44100 day average+0.0%
$4.44Last close
$4.4250 day average−0.5%
$4.38Swing low (Sep 21)−1.4%
$4.35Pivot S1−2.0%
$3.36200 day average−24.3%
$1.1752 week low−73.6%
Indicators
RSI (14)
53.36
Middle of its range
Neutral
MACD
0.26
Below its signal line
Bearish
Stochastic
59.1
Middle of its range
Neutral
ADX (14)
30.1
Trending up
Williams %R
-48.9
Oversold below −80, overbought above −20
Neutral
CCI (20)
66.2
Oversold below −100, overbought above 100
Neutral
Rate of change
−1.6%
Change over 10 sessions
Bearish
ATR (14)
$0.70
Typical daily range, 15.7% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Below
MA 200Below
What happened before, for TMCI
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how TMCI did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow TMCI usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How TMCI has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TMCI is in one of them and how their past TMCI trades turned out.
Treace Medical Concepts is a medical technology company based in Ponte Vedra, Florida. It makes surgical systems, instruments and implants for treating bunions and related midfoot deformities. Its main product line is the Lapiplasty 3D Bunion Correction System, which is supported by options for midfoot correction, minimally invasive osteotomy procedures and great toe fusions. The company sells mainly in the United States to surgeons who treat foot and ankle conditions, including surgical podiatrists and orthopaedic foot and ankle surgeons.